News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,103 Results
Type
Article (87769)
Company Profile (824)
Press Release (778494)
Multimedia
Podcasts (187)
Webinars (28)
Section
Business (233174)
Career Advice (4143)
Deals (39837)
Drug Delivery (144)
Drug Development (91362)
Employer Resources (203)
FDA (18359)
Job Trends (17414)
News (397719)
Policy (39949)
Tag
Academia (3006)
Academic (2)
Accelerated approval (26)
Adcomms (35)
Allergies (135)
Alliances (56981)
ALS (170)
Alzheimer's disease (1761)
Antibody-drug conjugate (ADC) (305)
Approvals (18473)
Artificial intelligence (581)
Autoimmune disease (135)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (190)
Biotechnology (488)
Bladder cancer (152)
Brain cancer (61)
Breast cancer (623)
Cancer (4701)
Cardiovascular disease (409)
Career advice (3565)
Career pathing (40)
CAR-T (291)
CDC (59)
Celiac Disease (1)
Cell therapy (788)
Cervical cancer (36)
Clinical research (76570)
Collaboration (1607)
Company closure (5)
Compensation (1074)
Complete response letters (65)
COVID-19 (2979)
CRISPR (93)
C-suite (746)
Cystic fibrosis (147)
Data (5850)
Decentralized trials (2)
Denatured (68)
Depression (133)
Diabetes (495)
Diagnostics (7172)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (273)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (226)
Earnings (99894)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134529)
Executive appointments (1010)
FDA (21232)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1439)
Gene editing (202)
Generative AI (60)
Gene therapy (628)
GLP-1 (1082)
Government (5421)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (55)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (277)
Immuno-oncology (41)
Indications (77)
Infectious disease (3249)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (217)
Interviews (816)
IPO (17943)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (38)
Legal (10153)
Liver cancer (95)
Longevity (14)
Lung cancer (647)
Lymphoma (359)
Machine learning (40)
Management (66)
Manufacturing (749)
MASH (166)
Medical device (14972)
Medtech (15012)
Mergers & acquisitions (22879)
Metabolic disorders (1295)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (323)
Neuropsychiatric disorders (86)
Neuroscience (2961)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (61)
Obesity (622)
Opinion (326)
Ovarian cancer (153)
Pain (192)
Pancreatic cancer (201)
Parkinson's disease (272)
Partnered (34)
Patents (470)
Patient recruitment (408)
Peanut (59)
People (66641)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23643)
Phase II (33234)
Phase III (25053)
Pipeline (3920)
Policy (319)
Postmarket research (3554)
Preclinical (10666)
Press Release (72)
Prostate cancer (229)
Psychedelics (53)
Radiopharmaceuticals (290)
Rare diseases (808)
Real estate (7436)
Recruiting (80)
Regulatory (28581)
Reports (65)
Research institute (2716)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (148)
Series A (239)
Series B (177)
Service/supplier (30)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4327)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (97)
The Weekly (117)
Vaccines (1108)
Venture capital (80)
Weight loss (434)
Women's health (79)
Worklife (21)
Date
Today (129)
Last 7 days (556)
Last 30 days (2634)
Last 365 days (33367)
2025 (32639)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (326)
Arkansas (14)
Asia (51326)
Australia (9019)
California (10843)
Canada (3174)
China (1062)
Colorado (455)
Connecticut (481)
Delaware (325)
Europe (117985)
Florida (1584)
Georgia (350)
Hawaii (3)
Idaho (68)
Illinois (894)
India (62)
Indiana (523)
Iowa (22)
Japan (379)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1396)
Massachusetts (8026)
Michigan (342)
Minnesota (629)
Mississippi (6)
Missouri (134)
Montana (34)
Nebraska (27)
Nevada (118)
New Hampshire (81)
New Jersey (2952)
New Mexico (32)
New York (2894)
North Carolina (1536)
North Dakota (10)
Northern California (5113)
Ohio (330)
Oklahoma (22)
Oregon (52)
Pennsylvania (2194)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4166)
Tennessee (168)
Texas (1705)
United States (39410)
Utah (323)
Vermont (1)
Virginia (272)
Washington D.C. (85)
Washington State (917)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
There are 867,103 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Autoimmune disease
Nektar Digs Into Mid-Stage Data to Establish Alopecia Efficacy of Rezpeg
Despite falling short of its primary Phase II objective, Nektar plans to push its T cell stimulator rezpeg into Phase III development.
December 17, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
Roche Makes Good on Dealmaking Promise With $1.1B Caris Cancer Collab
Roche CEO Thomas Schinecker said during the company’s Q3 call that it is “not done” with deals—a promise he delivered on with Tuesday’s solid tumor pact with AI-focused Caris Life Sciences.
December 17, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Rakovina Therapeutics Management to Attend Partnering Meetings During JPM Week, January in San Francisco, California
December 17, 2025
·
4 min read
Press Releases
Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
December 17, 2025
·
6 min read
Press Releases
Senzime’s Next-Generation TetraGraph System Receives Regulatory Approval in Japan
December 17, 2025
·
2 min read
Press Releases
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
December 17, 2025
·
1 min read
Press Releases
CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system
December 17, 2025
·
7 min read
Press Releases
Press release: Availability of the Q4 2025 Aide memoire
December 17, 2025
·
4 min read
Press Releases
111, Inc. Announces Third Quarter 2025 Unaudited Financial Results
December 17, 2025
·
22 min read
Press Releases
Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema
December 17, 2025
·
6 min read
1 of 86,711
Next
